Stockreport

Innate Pharma Provides Update on Lacutamab TELLOMAK Trial

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF MARSEILLE, France, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) announced [Read more]